Exozymes Inc.
EXOZNasdaqCIK 2010788HealthcareFiscal year ends Dec 31
All transactions: 3
Non-derivative transactions reported on Forms 4, newest first. Purchases and sales (codes P and S) are open-market trades; the other codes are grants, exercises, withholding and gifts. The reported price is as stated on the form, not a market price.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Insider | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-12 | Perriman Damien AlanChief Commercial Officer, Officer | Sale | 3,729 | $5.2096 | $19.4k | Form 4 |
| 2026-10-09 | Perriman Damien AlanChief Commercial Officer, Officer | Option exercise | 3,922 | not reported | not reported | Form 4 |
| 2024-11-08 | MDB Capital Holdings, LLC10% owner | Conversion | 122,657 | $6.40 | $785.0k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 26, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.